Medications for Lymphoma

54 results

  • allopurinol

    (allopurinol)
    Par Pharmaceutical, Inc.
    Allopurinol tablets are indicated for managing gout symptoms, cancer therapy-related elevated uric acid levels in adults and children, and recurrent calcium oxalate calculi in adults with high uric acid excretion. It is not recommended for treating asymptomatic hyperuricemia.
    Medication Details
    Drug Interactions

  • allopurinol

    (allopurinol)
    Mylan Pharmaceuticals Inc.
    Allopurinol tablets are indicated for managing gout symptoms, preventing elevated uric acid levels in patients with leukemia, lymphoma, and solid tumors undergoing treatment, and treating recurrent calcium oxalate stones in patients with high uric acid excretion. It is not recommended for asymptomatic hyperuricemia.
    Medication Details
    Drug Interactions

  • allopurinol

    (Allopurinol)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Allopurinol Tablets are indicated for managing gout symptoms, treating cancer patients with elevated uric acid levels due to therapy, and for adults with recurrent calcium oxalate stones despite lifestyle changes. It is not recommended for asymptomatic hyperuricemia.
    Medication Details
    Drug Interactions

  • bleomycin

    (BLEOMYCIN)
    Hospira, Inc.
    Bleomycin for Injection is a palliative treatment indicated for various neoplasms, including squamous cell carcinoma (head and neck, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), testicular carcinoma (embryonal cell, choriocarcinoma), and for managing malignant pleural effusions as a sclerosing agent.
    Medication Details
    Drug Interactions

  • bleomycin - bleomycin powder, for solution

    (Bleomycin)
    Northstar Rx Llc
    Bleomycin for Injection, USP is indicated as a palliative treatment for managing squamous cell carcinoma, lymphomas, and testicular carcinoma. It is also effective as a sclerosing agent for malignant pleural effusion and preventing recurrent effusions, either alone or in combination with other chemotherapy agents.
    Medication Details
    Drug Interactions

  • bleomycin - bleomycin sulfate powder, for solution

    (Bleomycin Sulfate)
    Meitheal Pharmaceuticals Inc.
    Bleomycin for Injection, USP is indicated for palliative treatment of various neoplasms, including squamous cell carcinoma (head and neck, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), and testicular carcinoma. It is also effective as a sclerosing agent for malignant pleural effusion management.
    Medication Details
    Drug Interactions

  • cyclophosphamide

    (cyclophosphamide)
    Baxter Healthcare Corporation
    Cyclophosphamide for Injection is indicated for treating various malignancies in adults and pediatric patients, including malignant lymphomas, multiple myeloma, leukemias, and specific cancers like breast and ovarian carcinoma. It's also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy fails.
    Medication Details
    Drug Interactions

  • cyclophosphamide

    (cyclophosphamide)
    Civica, Inc.
    Cyclophosphamide for Injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome unresponsive to corticosteroids.
    Medication Details
    Drug Interactions

  • cyclophosphamide

    (Cyclophosphamide)
    Amneal Pharmaceuticals LLC
    Cyclophosphamide for injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, several types of leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids.
    Medication Details
    Drug Interactions

  • cyclophosphamide

    (cyclophosphamide)
    Bamboo US Bidco LCC
    Cyclophosphamide is indicated for treating various malignant diseases, including lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids. Safety in adults for this condition is not established.
    Medication Details
    Drug Interactions